Literature DB >> 1169222

Antigen-antibody complexes in or on eosinophils in nasal secretions.

Y Fujita, E Rubinstein, D B Greco, R E Reisman, C E Arbesman.   

Abstract

The presence of IgG and ragweed antigen in or on eosinophils in the nasal secretions of ragweed-sensitive patients was investigated by radioautography using specifically purified 125I-labelled antibodies to the above substances. The results indicate a significant (p smaller than 0.001) uptake of antiragweed antibody and anti-IgE antibody by eosinophils. There was no evidence of significant uptake of anti-IgG. From the above findings it was postulated that during the pollination season exposure to ragweed leads to the formation of ragweed-IgE antibody complexes. This is followed by the infiltration of eosinophils into the local tissue and the subsequent phagocytosis of these antigen-antibody complexes by the eosinophils.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1169222     DOI: 10.1159/000231346

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  4 in total

1.  Studies on blood eosinophils. I. Patients with a transient eosinophilia.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

2.  Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E.

Authors:  M Joseph; A B Tonnel; A Capron; C Voisin
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

3.  High affinity IgE receptor (Fc epsilon RI) expression on eosinophils infiltrating the lesions and mite patch tested sites in atopic dermatitis.

Authors:  Y Tanaka; M Takenaka; Y Matsunaga; S Okada; S Anan; H Yoshida; C Ra
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  Eosinophilic lung disease: immunological studies of blood and alveolar eosinophils.

Authors:  L Prin; M Capron; P Gosset; B Wallaert; J P Kusnierz; O Bletry; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.